Literature DB >> 3771759

Methods for optimal recovery of Malassezia furfur from blood culture.

M J Marcon, D A Powell, D E Durrell.   

Abstract

Malassezia furfur, a recently described agent of catheter-associated sepsis, requires long-chained fatty acids for in vitro growth. To determine optimum conditions for recovery of the organism from blood culture, we compared a radiometric (BACTEC) with a lysis centrifugation-direct agar plating (Isolator) blood culture method. When blood culture isolates of M. furfur were suspended in phosphate-buffered saline and used as inocula, the BACTEC system detected the organisms radiometrically only when bottles were supplemented with lipid compounds; detection was often delayed (greater than or equal to 72 h) when small inoculum sizes were tested. The Isolator pediatric tube system detected growth of M. furfur within 48 h of plating onto a lipid-supplemented agar medium. Simulated blood culture experiments showed that the addition of whole human blood and Intralipid to the BACTEC 6B bottle was associated with rapid lysis of erythrocytes, accumulation of a chocolate brown sediment in the bottles, and fungicidal activity to the M. furfur isolates. In contrast, suspensions of M. furfur in whole human blood were stable for at least 8 h in Isolator tubes and quantitatively recoverable after plating onto agar. Of the two systems studied, the Isolator tube system provided a more suitable procedure for isolation of M. furfur from blood culture.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3771759      PMCID: PMC269010          DOI: 10.1128/jcm.24.5.696-700.1986

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  13 in total

1.  Evaluation of a lysis-centrifugation system for recovery of yeasts and filamentous fungi from blood.

Authors:  J Bille; L Stockman; G D Roberts; C D Horstmeier; D M Ilstrup
Journal:  J Clin Microbiol       Date:  1983-09       Impact factor: 5.948

2.  Quantitative culture of Pityrosporon orbiculare.

Authors:  J Faergemann
Journal:  Int J Dermatol       Date:  1984-06       Impact factor: 2.736

3.  Malassezia pulmonary vasculitis in an infant on long-term Intralipid therapy.

Authors:  R W Redline; B B Dahms
Journal:  N Engl J Med       Date:  1981-12-03       Impact factor: 91.245

4.  Systemic tinea versicolor, or how far can furfur go?

Authors:  C G Prober; S H Ein
Journal:  Pediatr Infect Dis       Date:  1984 Nov-Dec

5.  False no-growth blood cultures in pneumococcal pneumonia.

Authors:  C C Adeniyi-Jones; D L Stevens; E S Rasquinha
Journal:  J Clin Microbiol       Date:  1980-10       Impact factor: 5.948

6.  Systemic Malassezia furfur infections in patients receiving intralipid therapy.

Authors:  R W Redline; S S Redline; B Boxerbaum; B B Dahms
Journal:  Hum Pathol       Date:  1985-08       Impact factor: 3.466

7.  Micro-aerophilic and anaerobic growth of Pityrosporum species.

Authors:  J Faergemann; S Bernander
Journal:  Sabouraudia       Date:  1981-06

8.  Clinical evaluation of the lysis-centrifugation blood culture system for the detection of fungemia and comparison with a conventional biphasic broth blood culture system.

Authors:  J Bille; R S Edson; G D Roberts
Journal:  J Clin Microbiol       Date:  1984-02       Impact factor: 5.948

9.  Broviac catheter-related Malassezia furfur sepsis in five infants receiving intravenous fat emulsions.

Authors:  D A Powell; J Aungst; S Snedden; N Hansen; M Brady
Journal:  J Pediatr       Date:  1984-12       Impact factor: 4.406

10.  Catheter-related infection in infants due to an unusual lipophilic yeast--Malassezia furfur.

Authors:  J G Long; H L Keyserling
Journal:  Pediatrics       Date:  1985-12       Impact factor: 7.124

View more
  7 in total

Review 1.  Human infections due to Malassezia spp.

Authors:  M J Marcon; D A Powell
Journal:  Clin Microbiol Rev       Date:  1992-04       Impact factor: 26.132

Review 2.  Fungal blood cultures.

Authors:  A Telenti; G D Roberts
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-09       Impact factor: 3.267

3.  Malassezia furfur fungaemia in infants receiving intravenous lipid emulsions. A rarity or just underestimated?

Authors:  I Surmont; A Gavilanes; J Vandepitte; H Devlieger; E Eggermont
Journal:  Eur J Pediatr       Date:  1989-02       Impact factor: 3.183

4.  In vitro activity of systemic antifungal agents against Malassezia furfur.

Authors:  M J Marcon; D E Durrell; D A Powell; W J Buesching
Journal:  Antimicrob Agents Chemother       Date:  1987-06       Impact factor: 5.191

5.  Improved detection of Malassezia species in lipid-supplemented Peds Plus blood culture bottles.

Authors:  S C Nelson; Y C Yau; S E Richardson; A G Matlow
Journal:  J Clin Microbiol       Date:  1995-04       Impact factor: 5.948

6.  Malassezia furfur-related colonization and infection of central venous catheters. A prospective study in a pediatric intensive care unit.

Authors:  J Sizun; A Karangwa; J D Giroux; O Masure; A M Simitzis; D Alix; L De Parscau
Journal:  Intensive Care Med       Date:  1994-08       Impact factor: 17.440

7.  Cluster of Malassezia furfur pulmonary infections in infants in a neonatal intensive-care unit.

Authors:  H M Richet; M M McNeil; M C Edwards; W R Jarvis
Journal:  J Clin Microbiol       Date:  1989-06       Impact factor: 5.948

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.